IPO Trending
SAROJASME / NSEListed

Saroja Pharma Industries India Limited

Saroja Pharma Industries India Limited, incorporated in 2019, is engaged in trading, exporting, and supplying specialty chemicals and APIs. The company deals in three major product categories: chemicals, pharma intermediaries, and veterinary pharma APIs. It supplies products like Liquid Bromine (used as an agro-intermediate), Ethyl Acetate (used as an API solvent), and other pharma-based chemicals used in human and veterinary medicines. APIs or bulk actives are the key ingredients used in producing finished dosage forms like tablets, capsules, and liquids. The company exports its products to international markets including Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.

₹84 - ₹848.86x sub
Listed Price65.00
Listing Gain-22.62%
TimelineFixed Price Issue IPO
Open31 Aug 2023
Close05 Sep 2023
Allotment12 Sep 2023
Listing13 Sep 2023

Quota Reservation Portions

RetailPortion: 5,15,200 shares
47.49%
Nii(hni)Portion: 5,15,200 shares
47.49%
Market MakerPortion: 54,400 shares
5.01%

Minimum Application Bracket Matrix

Retail1 lots / 1,600 shares
₹1,34,400
HNI2 lots / 3,200 shares
₹2,68,800

About the Company

Saroja Pharma Industries India Limited, incorporated in 2019, is engaged in trading, exporting, and supplying specialty chemicals and APIs. The company deals in three major product categories: chemicals, pharma intermediaries, and veterinary pharma APIs. It supplies products like Liquid Bromine (used as an agro-intermediate), Ethyl Acetate (used as an API solvent), and other pharma-based chemicals used in human and veterinary medicines. APIs or bulk actives are the key ingredients used in producing finished dosage forms like tablets, capsules, and liquids. The company exports its products to international markets including Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.

Company Promoters

Mr. Biju Gopinathan NairMr. Manish Dasharath Kamble
Saroja Pharma Industries India Limited IPO Details | GMP, Allotment & Financials | IPO Trending